1st Quarter - Report

ZIMMER BIOMET, INC. for ZIMMER BIOMET, INC.

Firm
Client
Income
—
Expenses
$140,900
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

medical device tax repeal, S 17, S 262, HR 436, HR 488, HR 736 and corporate tax reform

LobbyistCovered position, as disclosed
CHRISTOPHER A CERONE —
WHITNEY TULL —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 436 (112th), H.R. 736 (112th), H.R. 488 (112th)

Health Issues HCR

FDA medical device user fee reauthorization, custom device issues and reprocessing of single use devices, and musculoskeletal health disparities congressional resolution

LobbyistCovered position, as disclosed
CHRISTOPHER A CERONE —
WHITNEY TULL —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.